A Study to Assess the Safety and Pharmacokinetics of AD-104-A

NCT05703282 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
32
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Addpharma Inc.